Docetaxel
Top View
- BRAJDC Protocol
- Original Article Docetaxel, 5-Fluorouracil, and Leucovorin As
- CY 2012 CDER Fast Track Calendar Year Approvals* Data As of 12-31-2012 Total of 20 Approvals
- 8. Malignant Disease and Immunosuppression
- Docetaxel-Fluorouracil-Folinic Acid-Oxaliplatin (FLOT)
- Chemotherapy Regimen: TC
- HOPA News Volume 10, Issue 1
- Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local Or Metastatic Esophageal Cancer
- Chemotherapy Protocol HEAD and NECK CANCER CISPLATIN (75)
- Mechanisms of Taxane Resistance
- Emetogenic Potential of Antineoplastic Agents
- Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
- Docetaxel for Breast Cancer Treatment-Side Effects on Ocular Surface, a Systematic Review
- Computationally Predicting Clinical Drug Combination Efficacy With
- Breast Pathway Group– TC (Docetaxel / Cyclophosphamide) in Early Breast Cancer
- Handling Cytostatic Drugs: Contents
- (PDF) Download
- TAXOTERE: TAXOTERE Safely and Effectively